Skip to main content
OpenTrials

Clinical trial condition

Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

138 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Gastroesophageal Junction Adenocarcinoma trial results

Active, not recruiting

First in Human Study of TORL-2-307-ADC in Participants With Advanced Cancer

NCT05156866

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Providence St. Jude Medical Center Fullerton, California, United States
  • UCLA - JCCC Clinical Research Unit Los Angeles, California, United States
  • Torrance Memorial Medical Torrance, California, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View Trial Details
Active, not recruiting

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03170960

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +68 more
Locations
  • Exelixis Clinical Site #53 Gilbert, Arizona, United States
  • Exelixis Clinical Site #18 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Duarte, California, United States
  • Exelixis Clinical Site #20 La Jolla, California, United States
View all 124 locations
View Trial Details
Active, not recruiting

A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

NCT05002127

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +8 more
Locations
  • The Oncology Institute of Hope & Innovation Anaheim, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • NEXT Virginia Fairfax, Virginia, United States
View all 83 locations
View Trial Details
Active, not recruiting

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection

NCT04581473

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Peking University Shenzhen Hospital Shenzhen, Guangzhou, China
View all 24 locations
View Trial Details
Active, not recruiting

First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

NCT05159440

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Providence St. Jude Medical Center Fullerton, California, United States
  • UCLA - JCCC Clinical Research Unit Los Angeles, California, United States
  • Torrance Memorial Medical Torrance, California, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View Trial Details
Active, not recruiting

Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients

NCT03760822

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +9 more
Locations
  • CH - Abbeville, France
  • CH - Albi Albi, France
  • PRIVEE - L'Europe Amiens, France
  • CAC - ICO Site Paul Papin Angers, France
View all 38 locations
View Trial Details
Completed

A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction

NCT04661150

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • West China Hospital, Sichuan University Chengdu, China
  • Nanfang Hospital, Southern Medical University Guangzhou, China
  • Harbin Medical University Cancer Hospital Harbin, China
View Trial Details

Related conditions